| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. | Chief Medical Officer | Restricted Stock Units | 59K | $512K | $8.68 | Jan 3, 2025 | Direct |
| EyePoint Pharmaceuticals, Inc. | Chief Medical Officer | Common Stock | 0 | $0 | $11.61 | Nov 11, 2025 | Direct |
| EyePoint Pharmaceuticals, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 117K | Jan 3, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals, Inc. | Nov 11, 2025 | 1 | -$31.6K | 4 | Nov 12, 2025 | Chief Medical Officer |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jan 3, 2025 | 2 | $0 | 4 | Jan 7, 2025 | Chief Medical Officer |
| EYPT | EyePoint Pharmaceuticals, Inc. | Mar 1, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Chief Medical Officer |
| EYPT | EyePoint Pharmaceuticals, Inc. | Mar 1, 2024 | 0 | $0 | 3 | Mar 4, 2024 | Chief Medical Officer |